The aim of the current study was to investigate SERT binding in the midbrain of patients with epilepsy with symptoms of depression, and to determine differences in SERT binding compared to patients with epilepsy without symptoms of depression. This evidence concerns the gene SLC6A4 and depressive symptom measurement.